Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Profit before tax (PBT) soared 119.17% YoY to Rs 21.04 crore in Q1 FY27.
EBITDA stood at Rs 30 crore in Q1 FY27, down 4.46% from Rs 31.40 crore in Q1 FY26. Consequently, EBITDA margin contracted to 4.19% from 4.90% in the year-ago quarter.
On the geographical front, the domestic market contributed 75% of the company's revenue, while exports accounted for the remaining 25%.
The bioenergy business generated revenue of Rs 474 crore, registering a growth of 23.9% YoY. Revenue from the high-purity business increased 14.6% YoY to Rs 85 crore, while engineering business revenue declined 14.3% to Rs 157 crore.
The company reported order intake of Rs 1,000 crore during the quarter, indicating continued demand across its business segments.
Ashish Gaikwad, MD, Praj Industries said, “While the external business environment remained uncertain, we have made a definite progress on few long-term growth vectors. Key developments this quarter include securing a Bio-IBA order for the country’s first commercial scale demo plant, signing a long-term framework agreement for precision fabrication and modularization solutions for hyperscale data centers, and receiving first order from a leading semiconductor player for ultra-pure water and ZLD solutions. As we move further into the financial year, we expect to build on this momentum and deliver improved performance.”
Praj Industries is a globally recognized biotechnology and engineering company offering sustainable solutions across bio-energy, water purification, process equipment, breweries, and wastewater treatment.
For the full year,net profit declined 89.11% to Rs 23.84 crore in the year ended March 2026 as against Rs 218.91 crore during the previous year ended March 2025. Sales declined 1.86% to Rs 3167.88 crore in the year ended March 2026 as against Rs 3228.04 crore during the previous year ended March 2025.
Praj Industries today announced the establishment of an Advanced Precision Fermentation Lab at Praj Matrix to drive next-genera on biotechnology and accelerate India's transition to high-performance, low-carbon biomanufacturing. Announced on the occasion of the 18th Praj Matrix Foundation Day, the initiative reflects Praj's commitment to advancing India's bioeconomy through cutting-edge innovation, skill development, and strong academia–industry collaboration.
The new lab, one of a kind globally, will focus on high-capacity, AI-enabled precision fermentation and next-genera on bioprocesses to improve efficiency, reduce scale-up risks, and enhance process reliability. It will enable Praj and Praj HiPurity Systems (Praj's wholly owned subsidiary in Mumbai), known for its expertise in precision fermenters and ultra-pure water systems for the pharmaceutical and biotech industries, to deliver advanced fermentation solutions to the pharmaceutical, food, cosmetics and to biofuels and beverage sectors. The facility is being developed to further strengthen Praj's capabilities in next generation biomanufacturing.
Combined with BRIC–NCCS's strengths in microbial research, genomics, and cell culture repositories, this creates a strong synergy—integra ng discovery, process development, and high-purity manufacturing to accelerate innovation.
Aligned with the Government of India's BioE3 (Biotechnology for Economy, Environment and Employment) Initiative, steered by the Department of Biotechnology, the initiative supports the national vision of building a globally competitive, sustainable biomanufacturing ecosystem.